Biotech News
TherapeuticsMD Announces Third Quarter 2023 Financial Results
ir.therapeuticsmd.com2026-05-06 15:14 EST
Focus remains on cost control to maximize the value of our royalty assets Company announces evaluation of strategic alternatives BOCA RATON, Fla. --(BUSINESS WIRE)--Nov. 14, 2023-- TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical